Myocardial Stunning

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-02-25
Clinical Trial Update: Ranolazine a Potential New Therapeutic Application [Phase 4]
Phase 4 trial for ranolazine as a potential new indication was withdrawn.